Tenon Medical, Inc. (TNON)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 600K 1.2M 1.8M Q1 '21: 15K Q2 '21: 22K Q3 '21: 70K Q4 '21: 53K Q1 '22: 71K Q2 '22: 135K Q3 '22: 208K Q4 '22: 277K Q1 '23: 433K Q2 '23: 743K Q3 '23: 944K Q4 '23: 808K Q1 '24: 719K Q2 '24: 901K Q3 '24: 887K Q4 '24: 770K Q1 '25: 726K Q2 '25: 564K Q3 '25: 1.2M Q4 '25: 1.5M Q1 '26: 1.4M Q2 '26: 1.3M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-350K 0 350K 700K 1.1M Q1 '21: 4K Q2 '21: 13K Q3 '21: 52K Q4 '21: 36K Q1 '22: -204K Q2 '22: -136K Q3 '22: -94K Q4 '22: -207K Q1 '23: -47K Q2 '23: 194K Q3 '23: 535K Q4 '23: 559K Q1 '24: 470K Q2 '24: 470K Q3 '24: 418K Q4 '24: 353K Q1 '25: 323K Q2 '25: 245K Q3 '25: 773K Q4 '25: 1M Q1 '26: 945K Q2 '26: 814K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -189K Q2 '21: -1.6M Q3 '21: -2.1M Q4 '21: -2.6M Q1 '22: -2.1M Q2 '22: -5.5M Q3 '22: -3.3M Q4 '22: -7.9M Q1 '23: -4.9M Q2 '23: -4.3M Q3 '23: -3.4M Q4 '23: -3.1M Q1 '24: -3.5M Q2 '24: -3.9M Q3 '24: -3.2M Q4 '24: -3.2M Q1 '25: -3.7M Q2 '25: -2.9M Q3 '25: -3.4M Q4 '25: -2.9M Q1 '26: -3.3M Q2 '26: -3.4M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -200K Q2 '21: -1.7M Q3 '21: -2.3M Q4 '21: -2.8M Q1 '22: -2.4M Q2 '22: -5.5M Q3 '22: -3.2M Q4 '22: -7.9M Q1 '23: -4.8M Q2 '23: -4.3M Q3 '23: -3.3M Q4 '23: -3.1M Q1 '24: -3.6M Q2 '24: -3.8M Q3 '24: -3.2M Q4 '24: -3.1M Q1 '25: -3.6M Q2 '25: -2.8M Q3 '25: -3.3M Q4 '25: -2.8M Q1 '26: -3.5M Q2 '26: -4M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 200K 400K 600K Q1 '21: 11K Q2 '21: 9K Q3 '21: 18K Q4 '21: 17K Q1 '22: 275K Q2 '22: 271K Q3 '22: 302K Q4 '22: 484K Q1 '23: 480K Q2 '23: 549K Q3 '23: 409K Q4 '23: 249K Q1 '24: 249K Q2 '24: 431K Q3 '24: 469K Q4 '24: 417K Q1 '25: 403K Q2 '25: 319K Q3 '25: 400K Q4 '25: 464K Q1 '26: 434K Q2 '26: 465K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '21: -162K Q2 '21: -1M Q3 '21: -1.4M Q4 '21: -1.7M Q1 '22: -2.5M Q2 '22: -2.8M Q3 '22: -3.4M Q4 '22: -3.4M Q1 '23: -3.6M Q2 '23: -3.2M Q3 '23: -3.2M Q4 '23: -2.3M Q1 '24: -2.3M Q2 '24: -2.4M Q3 '24: -2.3M Q4 '24: -2.8M Q1 '25: -2.5M Q2 '25: -2.2M Q3 '25: -3.8M Q4 '25: -2.2M Q1 '26: -3M Q2 '26: -2.8M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '21: -162K Q2 '21: -1M Q3 '21: -1.4M Q4 '21: -1.8M Q1 '22: -2.6M Q2 '22: -2.8M Q3 '22: -3.5M Q4 '22: -4M Q1 '23: -3.7M Q2 '23: -3.3M Q3 '23: -3.2M Q4 '23: -2.4M Q1 '24: -2.5M Q2 '24: -2.4M Q3 '24: -2.4M Q4 '24: -2.8M Q3 '25: -3.9M Q4 '25: -2.4M Q1 '26: -3M Q2 '26: -2.9M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 4K 8K 12K Q2 '21: 830 Q3 '21: 919 Q1 '22: 990 Q2 '22: 8.4K Q3 '22: 1.1K Q1 '23: 1.1K Q2 '23: 1.3K Q3 '23: 285 Q1 '24: 357 Q2 '24: 469 Q3 '24: 877 Q1 '25: 3.6K Q2 '25: 217 Q3 '25: 8.2K Q1 '26: 11.3K Q2 '26: 328 Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.